Veterinary Medicines

Panacur 10 % (100 mg/ml), suspensão oral para bovinos e equinos

Authorised
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Panacur 10 % (100 mg/ml), suspensão oral para bovinos e equinos
Active substance:
  • Fenbendazole
Target species:
  • Cattle
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        11
        day
      • Milk
        6
        day
    • Horse
      • Meat and offal
        8
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • MSD Animal Health Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.A.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 824/01/14NFVPT
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 15/06/2023
Updated on: 17/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."